Latest filing published 28 Jul 2014 for Karyopharm Therapeutics Inc., €1.3M.
Insider track record
No signal scores available.
Plio Ltd: trading record in brief
Plio Ltd appears in our data through filings on Karyopharm Therapeutics Inc. shares, published by SEC (Form 4). Over a trading history stretching from 12 November 2013 to 23 July 2014, the count stands at 4 filings.
The open-market record consists of 2 sales worth €14.5M, with no purchase. 2014 to date brings no purchases and 2 sales.
On 28 July 2014 came the latest disclosure, an open-market sale for €1.3M in Karyopharm Therapeutics Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Plio Ltd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 50,000 shares@ US$35.5437COMMON STOCKSEC:0001213900-14-005161:0
- 500,000 shares@ US$35.5437COMMON STOCKSEC:0001213900-14-005154:0
- 3,193,473 shares0COMMON STOCKSEC:0001213900-13-006615:0
- 3,193,473 shares0COMMON STOCKSEC:0001213900-13-006615:1
4 of 4 declarations
